Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Jeffrey Montgomery

Concepts (437)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Urinary Bladder Neoplasms
52
2024
156
10.080
 Why?
Cystectomy
31
2024
49
6.440
 Why?
Prostatic Neoplasms
43
2024
394
5.180
 Why?
Kidney Neoplasms
22
2018
176
2.830
 Why?
Carcinoma, Transitional Cell
13
2023
52
2.750
 Why?
Prostatectomy
22
2023
81
2.430
 Why?
Nephrectomy
19
2016
83
2.040
 Why?
Lymph Node Excision
7
2024
137
1.870
 Why?
Urinary Diversion
6
2021
44
1.680
 Why?
Laparoscopy
13
2014
168
1.580
 Why?
Prostate
14
2024
117
1.580
 Why?
Quality of Life
12
2023
839
1.490
 Why?
Aged
81
2024
9405
1.390
 Why?
Male
120
2024
25399
1.290
 Why?
Middle Aged
87
2024
12206
1.240
 Why?
Humans
149
2024
50208
1.200
 Why?
Neoadjuvant Therapy
12
2024
117
1.170
 Why?
Neoplasm Staging
25
2024
738
1.050
 Why?
BCG Vaccine
7
2024
16
1.000
 Why?
Robotics
8
2015
43
0.990
 Why?
Postoperative Complications
15
2021
996
0.960
 Why?
Retrospective Studies
52
2024
6134
0.950
 Why?
Carcinoma, Renal Cell
10
2016
105
0.930
 Why?
Penile Neoplasms
3
2024
45
0.900
 Why?
Exercise Therapy
1
2023
98
0.840
 Why?
Ureter
3
2016
37
0.840
 Why?
Exercise
2
2023
503
0.830
 Why?
Hernia
2
2020
6
0.790
 Why?
Neoplasm Recurrence, Local
15
2024
613
0.740
 Why?
Intestine, Small
2
2020
108
0.730
 Why?
Herniorrhaphy
1
2020
23
0.710
 Why?
Treatment Outcome
30
2024
5155
0.710
 Why?
Physical Fitness
1
2020
55
0.710
 Why?
Patient Readmission
6
2021
217
0.700
 Why?
Intestinal Obstruction
1
2020
36
0.700
 Why?
Aged, 80 and over
26
2024
3154
0.680
 Why?
Image-Guided Biopsy
6
2024
33
0.670
 Why?
Watchful Waiting
7
2019
27
0.650
 Why?
Biopsy
17
2023
590
0.630
 Why?
Neoplasm Invasiveness
14
2024
266
0.620
 Why?
Ureteral Neoplasms
2
2018
12
0.620
 Why?
Female
60
2024
26635
0.600
 Why?
Magnetic Resonance Imaging
10
2023
1541
0.560
 Why?
Urinary Bladder
7
2018
92
0.560
 Why?
Testicular Neoplasms
4
2024
64
0.560
 Why?
Convalescence
1
2016
6
0.550
 Why?
Carcinoma, Squamous Cell
4
2024
318
0.550
 Why?
Neoplasms, Germ Cell and Embryonal
3
2024
36
0.510
 Why?
Prospective Studies
17
2024
2379
0.500
 Why?
Urothelium
4
2018
18
0.500
 Why?
Carcinoma in Situ
4
2024
72
0.500
 Why?
Chemotherapy, Adjuvant
8
2024
120
0.490
 Why?
Ileum
1
2014
87
0.480
 Why?
Urologic Neoplasms
3
2019
12
0.480
 Why?
Choline
3
2019
61
0.470
 Why?
Neoplasm Grading
13
2020
123
0.460
 Why?
Medical Oncology
4
2021
95
0.460
 Why?
Quality Indicators, Health Care
1
2013
86
0.420
 Why?
Needles
3
2021
23
0.410
 Why?
Administration, Intravesical
7
2024
16
0.400
 Why?
Urologic Surgical Procedures
3
2016
27
0.400
 Why?
Disease Progression
8
2024
831
0.400
 Why?
Lymphatic Metastasis
4
2024
227
0.390
 Why?
Antineoplastic Agents
3
2021
1186
0.390
 Why?
Survival Rate
9
2021
901
0.380
 Why?
Biopsy, Needle
5
2021
181
0.380
 Why?
Prostate-Specific Antigen
8
2021
47
0.380
 Why?
Testicular Diseases
1
2011
4
0.380
 Why?
Risk Assessment
10
2019
1262
0.370
 Why?
Urogenital Neoplasms
1
2010
9
0.370
 Why?
Tumor Burden
6
2016
131
0.370
 Why?
Magnetic Resonance Imaging, Interventional
4
2024
5
0.360
 Why?
Muscle Neoplasms
1
2010
17
0.360
 Why?
Registries
4
2023
522
0.360
 Why?
Fluorine Radioisotopes
2
2019
24
0.340
 Why?
Retroperitoneal Space
5
2016
32
0.340
 Why?
Adult
27
2024
13324
0.340
 Why?
Antineoplastic Combined Chemotherapy Protocols
4
2024
990
0.340
 Why?
Recovery of Function
2
2023
187
0.330
 Why?
Psoas Muscles
2
2021
2
0.330
 Why?
Self Report
1
2010
199
0.330
 Why?
Organ Sparing Treatments
4
2018
55
0.330
 Why?
Telomerase
2
2019
27
0.320
 Why?
Patient Selection
5
2019
253
0.310
 Why?
Urinary Incontinence
3
2023
38
0.300
 Why?
Deoxycytidine
3
2024
28
0.300
 Why?
Seat Belts
2
2017
16
0.300
 Why?
Child Restraint Systems
2
2017
18
0.300
 Why?
Urinary Catheterization
1
2007
24
0.300
 Why?
Urethral Stricture
1
2007
20
0.290
 Why?
Positron-Emission Tomography
2
2019
294
0.290
 Why?
Time Factors
13
2020
2922
0.290
 Why?
Primary Health Care
1
2011
360
0.290
 Why?
Rectum
2
2024
54
0.280
 Why?
Cohort Studies
8
2021
1422
0.280
 Why?
Tomography, X-Ray Computed
3
2021
1161
0.280
 Why?
Length of Stay
6
2020
621
0.270
 Why?
Guideline Adherence
3
2017
133
0.270
 Why?
Patient Discharge
3
2017
319
0.260
 Why?
Pain Measurement
2
2017
240
0.260
 Why?
Health Status
2
2015
296
0.260
 Why?
Kidney
4
2014
672
0.260
 Why?
Patient Participation
2
2016
66
0.250
 Why?
Bandages
1
2005
25
0.250
 Why?
Carcinoma
2
2018
139
0.250
 Why?
Adenoviridae
2
2024
51
0.240
 Why?
Surgical Wound Infection
1
2005
116
0.240
 Why?
Neurilemmoma
1
2004
24
0.240
 Why?
Age Factors
7
2021
1092
0.240
 Why?
Quality Improvement
3
2016
209
0.240
 Why?
Antimetabolites, Antineoplastic
1
2024
38
0.240
 Why?
Multivariate Analysis
8
2016
581
0.240
 Why?
Adenocarcinoma
3
2016
397
0.240
 Why?
Organoids
1
2024
40
0.240
 Why?
Immunohistochemistry
5
2024
978
0.230
 Why?
Venous Thrombosis
1
2005
90
0.230
 Why?
Perineum
1
2024
24
0.230
 Why?
Follow-Up Studies
9
2024
2190
0.230
 Why?
Decision Making
2
2016
267
0.220
 Why?
Antibiotic Prophylaxis
1
2024
61
0.220
 Why?
Clinical Competence
3
2016
392
0.220
 Why?
Practice Guidelines as Topic
2
2018
449
0.220
 Why?
Urethra
3
2014
89
0.210
 Why?
Prognosis
9
2021
1954
0.210
 Why?
Erectile Dysfunction
3
2023
85
0.210
 Why?
United States
12
2020
4874
0.200
 Why?
DNA, Neoplasm
2
2018
147
0.200
 Why?
Logistic Models
7
2021
889
0.200
 Why?
Feasibility Studies
2
2020
380
0.190
 Why?
Vital Statistics
1
2021
3
0.190
 Why?
Mandatory Reporting
1
2021
12
0.190
 Why?
Death Certificates
1
2021
16
0.190
 Why?
DNA Mutational Analysis
3
2018
176
0.190
 Why?
Birth Certificates
1
2021
20
0.190
 Why?
Cell Transdifferentiation
1
2021
8
0.190
 Why?
Neuroendocrine Cells
1
2021
10
0.190
 Why?
Cost-Benefit Analysis
2
2019
273
0.190
 Why?
Reproducibility of Results
7
2018
1185
0.190
 Why?
Urethral Diseases
2
2013
7
0.190
 Why?
Radiosurgery
1
2022
118
0.190
 Why?
Radiography, Abdominal
1
2020
27
0.180
 Why?
Mutation
5
2019
1294
0.180
 Why?
Reimbursement, Incentive
1
2020
13
0.180
 Why?
Genetic Vectors
1
2020
125
0.180
 Why?
Randomized Controlled Trials as Topic
4
2023
550
0.180
 Why?
Genetic Therapy
1
2020
114
0.170
 Why?
Ablation Techniques
1
2019
21
0.170
 Why?
Abdominal Pain
1
2020
81
0.170
 Why?
Venous Thromboembolism
1
2020
68
0.170
 Why?
Diagnosis, Differential
2
2020
1043
0.170
 Why?
Genetic Predisposition to Disease
5
2024
509
0.160
 Why?
Adjuvants, Immunologic
3
2024
51
0.160
 Why?
Urinary Tract
1
2018
26
0.160
 Why?
Predictive Value of Tests
6
2018
905
0.160
 Why?
Forecasting
1
2019
150
0.160
 Why?
Lymphocytes
1
2019
154
0.160
 Why?
Patient-Centered Care
1
2020
131
0.160
 Why?
Obesity
2
2006
1108
0.160
 Why?
RNA, Neoplasm
1
2018
45
0.160
 Why?
Genetic Heterogeneity
1
2018
18
0.160
 Why?
Drug Resistance, Neoplasm
1
2020
314
0.160
 Why?
Neutrophils
1
2019
148
0.160
 Why?
Programmed Cell Death 1 Receptor
1
2018
39
0.150
 Why?
Retroperitoneal Neoplasms
1
2018
20
0.150
 Why?
Orchiectomy
1
2018
41
0.150
 Why?
Pain, Postoperative
2
2016
158
0.150
 Why?
Transurethral Resection of Prostate
1
2018
10
0.150
 Why?
Internship and Residency
2
2021
441
0.150
 Why?
Body Size
1
2017
27
0.150
 Why?
Electronic Health Records
1
2020
213
0.150
 Why?
Quality Assurance, Health Care
1
2018
149
0.150
 Why?
Physician-Patient Relations
2
2016
141
0.150
 Why?
Anticoagulants
1
2020
253
0.150
 Why?
Inguinal Canal
1
2017
11
0.150
 Why?
Urodynamics
2
2014
23
0.150
 Why?
Databases, Factual
2
2021
657
0.150
 Why?
Sarcosine
1
2017
3
0.150
 Why?
Amino Acid Transport Systems
1
2017
5
0.150
 Why?
Body Height
1
2017
65
0.140
 Why?
Carbon Radioisotopes
1
2017
53
0.140
 Why?
Transcriptome
2
2018
320
0.140
 Why?
Safety
1
2017
77
0.140
 Why?
Guidelines as Topic
1
2017
111
0.140
 Why?
Disease-Free Survival
5
2016
454
0.140
 Why?
Replantation
1
2016
11
0.140
 Why?
Scrotum
2
2015
30
0.140
 Why?
Nomograms
1
2016
4
0.140
 Why?
Protons
1
2017
69
0.140
 Why?
Laparotomy
1
2016
34
0.140
 Why?
Natural Orifice Endoscopic Surgery
1
2016
4
0.140
 Why?
Research Report
1
2016
16
0.130
 Why?
Patient Preference
1
2016
37
0.130
 Why?
Kaplan-Meier Estimate
5
2017
465
0.130
 Why?
Urinary Retention
2
2007
7
0.130
 Why?
Physicians
2
2016
230
0.130
 Why?
Checklist
1
2016
29
0.130
 Why?
Ureteral Obstruction
1
2016
61
0.130
 Why?
Time-to-Treatment
1
2016
66
0.130
 Why?
Preoperative Period
3
2021
47
0.130
 Why?
Genital Neoplasms, Male
1
2015
2
0.130
 Why?
Sensitivity and Specificity
5
2018
863
0.130
 Why?
Paget Disease, Extramammary
1
2015
5
0.130
 Why?
Social Networking
1
2015
15
0.130
 Why?
Body Weight
1
2017
512
0.130
 Why?
Feedback
1
2015
52
0.120
 Why?
Lymph Nodes
1
2017
263
0.120
 Why?
Radiopharmaceuticals
1
2016
208
0.120
 Why?
Video Recording
1
2015
80
0.120
 Why?
Treatment Failure
2
2017
116
0.120
 Why?
Peer Group
1
2015
53
0.120
 Why?
Informed Consent
1
2015
97
0.120
 Why?
Papilloma, Inverted
1
2014
1
0.120
 Why?
Proto-Oncogene Proteins B-raf
1
2015
79
0.120
 Why?
Equipment Design
3
2021
285
0.120
 Why?
Proto-Oncogene Proteins p21(ras)
1
2014
66
0.120
 Why?
Computer Simulation
1
2015
280
0.120
 Why?
Matched-Pair Analysis
1
2013
11
0.120
 Why?
Blood Loss, Surgical
5
2016
72
0.120
 Why?
Urinary Incontinence, Stress
1
2014
29
0.110
 Why?
Kidney Diseases
1
2016
214
0.110
 Why?
Body Mass Index
3
2020
656
0.110
 Why?
Diffusion of Innovation
1
2013
44
0.110
 Why?
Adenoma
1
2015
110
0.110
 Why?
Carcinoma, Papillary
1
2014
49
0.110
 Why?
General Surgery
1
2015
106
0.110
 Why?
Technology Transfer
1
2013
2
0.110
 Why?
Longitudinal Studies
2
2018
695
0.110
 Why?
Mitomycin
1
2013
20
0.110
 Why?
Radiotherapy, Adjuvant
2
2018
61
0.110
 Why?
Severity of Illness Index
2
2014
951
0.110
 Why?
Accreditation
1
2013
60
0.110
 Why?
Education, Medical, Continuing
1
2013
68
0.110
 Why?
Peripheral Nerves
1
2013
49
0.100
 Why?
Operating Rooms
1
2012
27
0.100
 Why?
Community Health Centers
1
2012
30
0.100
 Why?
Pathology, Clinical
1
2012
24
0.100
 Why?
Referral and Consultation
2
2012
285
0.100
 Why?
Receptors, Androgen
2
2002
46
0.100
 Why?
Algorithms
1
2015
618
0.100
 Why?
Combined Modality Therapy
3
2021
636
0.100
 Why?
Risk Factors
5
2017
3629
0.090
 Why?
Neoplasms
1
2021
1249
0.090
 Why?
Perioperative Care
1
2011
42
0.090
 Why?
Seminal Vesicles
2
2022
13
0.090
 Why?
Multicenter Studies as Topic
2
2023
88
0.090
 Why?
Medicare
3
2020
249
0.080
 Why?
Skin Neoplasms
1
2015
492
0.080
 Why?
Phantoms, Imaging
2
2020
121
0.080
 Why?
Proportional Hazards Models
3
2016
410
0.080
 Why?
Markov Chains
2
2019
30
0.080
 Why?
SEER Program
3
2014
92
0.080
 Why?
Carboplatin
2
2022
53
0.080
 Why?
Immunotherapy
1
2010
240
0.080
 Why?
Postoperative Care
2
2020
102
0.080
 Why?
Healthcare Disparities
1
2011
268
0.080
 Why?
Ureteroscopy
1
2007
12
0.080
 Why?
Sarcopenia
2
2021
84
0.080
 Why?
Automobiles
2
2017
14
0.080
 Why?
Incidence
2
2021
1006
0.070
 Why?
Chi-Square Distribution
3
2013
278
0.070
 Why?
Pandemics
2
2023
562
0.070
 Why?
Diverticulum
1
2007
21
0.070
 Why?
Peritoneum
1
2007
17
0.070
 Why?
Delphi Technique
2
2018
49
0.070
 Why?
Cisplatin
2
2022
278
0.070
 Why?
Gene Amplification
2
2018
57
0.070
 Why?
Societies, Medical
2
2018
177
0.070
 Why?
Aftercare
2
2018
75
0.070
 Why?
Gene Expression Profiling
2
2024
1037
0.070
 Why?
Adrenalectomy
1
2006
34
0.070
 Why?
Postoperative Hemorrhage
1
2006
51
0.070
 Why?
Promoter Regions, Genetic
2
2019
475
0.070
 Why?
Case-Control Studies
3
2014
1126
0.070
 Why?
Fibrin Tissue Adhesive
1
2005
12
0.060
 Why?
Sex Factors
2
2020
697
0.060
 Why?
Tissue Adhesives
1
2005
13
0.060
 Why?
Hand
1
2005
52
0.060
 Why?
Intestines
1
2006
168
0.060
 Why?
Genomics
2
2018
285
0.060
 Why?
Suture Techniques
1
2005
59
0.060
 Why?
Renal Insufficiency
1
2005
109
0.060
 Why?
Diabetes Complications
1
2005
119
0.060
 Why?
Chromosomes, Human, Pair 12
1
2024
14
0.060
 Why?
Glomerular Filtration Rate
2
2016
111
0.060
 Why?
Vulnerable Populations
1
2024
45
0.060
 Why?
Superior Mesenteric Artery Syndrome
1
2004
4
0.060
 Why?
Mediastinal Neoplasms
1
2024
19
0.060
 Why?
Drug Screening Assays, Antitumor
1
2024
140
0.060
 Why?
Communication
2
2016
246
0.060
 Why?
Hernia, Inguinal
1
2004
18
0.060
 Why?
Phenotype
2
2018
733
0.060
 Why?
Intraoperative Complications
1
2005
112
0.060
 Why?
High-Throughput Nucleotide Sequencing
2
2015
170
0.060
 Why?
Child
3
2024
6851
0.060
 Why?
Cell Line, Tumor
2
2018
1416
0.060
 Why?
Neoplasms, Second Primary
1
2024
78
0.060
 Why?
Quality of Health Care
2
2015
187
0.050
 Why?
Papillomavirus Infections
2
2015
155
0.050
 Why?
Ischemia
1
2004
153
0.050
 Why?
Perioperative Period
2
2013
22
0.050
 Why?
Trinucleotide Repeats
1
2002
4
0.050
 Why?
Liver Cirrhosis
1
2005
219
0.050
 Why?
Chromosome Aberrations
1
2024
297
0.050
 Why?
Muscles
1
2022
102
0.050
 Why?
Odds Ratio
2
2014
546
0.050
 Why?
Polymorphism, Restriction Fragment Length
1
2002
66
0.050
 Why?
Smoking
1
2005
512
0.050
 Why?
Gallium Isotopes
1
2021
2
0.050
 Why?
Accidents, Traffic
2
2017
87
0.050
 Why?
Gallium Radioisotopes
1
2021
10
0.050
 Why?
Edetic Acid
1
2021
14
0.050
 Why?
Geography
1
2021
60
0.050
 Why?
Androgen Antagonists
1
2021
11
0.050
 Why?
Radiotherapy, Intensity-Modulated
2
2013
174
0.050
 Why?
Public Health
1
2023
203
0.050
 Why?
Polymorphism, Single Nucleotide
1
2024
485
0.050
 Why?
Quarantine
1
2021
12
0.050
 Why?
Internationality
1
2021
36
0.050
 Why?
Neoplasm Metastasis
2
2017
236
0.050
 Why?
Drug Dosage Calculations
1
2020
10
0.050
 Why?
Motion
1
2020
19
0.050
 Why?
Enoxaparin
1
2020
27
0.040
 Why?
Fellowships and Scholarships
1
2021
111
0.040
 Why?
Finite Element Analysis
1
2020
10
0.040
 Why?
Drug Monitoring
1
2020
78
0.040
 Why?
Young Adult
2
2024
3981
0.040
 Why?
Pelvis
1
2020
67
0.040
 Why?
DNA-Directed RNA Polymerases
1
2019
14
0.040
 Why?
Abdomen
1
2020
77
0.040
 Why?
Heparin
1
2020
92
0.040
 Why?
Postoperative Period
1
2020
168
0.040
 Why?
Social Behavior
1
2019
71
0.040
 Why?
Urine
1
2018
23
0.040
 Why?
Adolescent
2
2024
6390
0.040
 Why?
Cytodiagnosis
1
2018
42
0.040
 Why?
Diagnostic Errors
1
2018
63
0.040
 Why?
Single-Blind Method
1
2018
115
0.040
 Why?
Image Processing, Computer-Assisted
1
2019
246
0.040
 Why?
DNA Copy Number Variations
1
2018
110
0.040
 Why?
Genome, Human
1
2018
111
0.040
 Why?
Quality-Adjusted Life Years
1
2018
63
0.040
 Why?
Sequence Analysis, RNA
1
2018
91
0.040
 Why?
Health Services Accessibility
2
2012
399
0.040
 Why?
Delivery of Health Care, Integrated
1
2018
44
0.040
 Why?
Hospitalization
2
2017
655
0.040
 Why?
Random Allocation
1
2018
282
0.040
 Why?
Nephrons
1
2016
6
0.040
 Why?
Consensus
1
2018
150
0.040
 Why?
Tissue Distribution
1
2017
163
0.040
 Why?
Hospital Communication Systems
1
2016
6
0.030
 Why?
Dose-Response Relationship, Drug
1
2020
1378
0.030
 Why?
Failure to Thrive
1
2016
18
0.030
 Why?
Coitus
1
2016
18
0.030
 Why?
Anastomosis, Surgical
1
2016
66
0.030
 Why?
Salvage Therapy
1
2017
139
0.030
 Why?
Early Detection of Cancer
1
2018
167
0.030
 Why?
Creatinine
1
2016
141
0.030
 Why?
Radiometry
1
2017
122
0.030
 Why?
Cyclin-Dependent Kinase 4
1
2015
11
0.030
 Why?
Multiplex Polymerase Chain Reaction
1
2015
10
0.030
 Why?
Genes, erbB-1
1
2015
8
0.030
 Why?
Operative Time
1
2016
73
0.030
 Why?
Tape Recording
1
2015
6
0.030
 Why?
Molecular Imaging
1
2016
53
0.030
 Why?
Fever
1
2016
115
0.030
 Why?
Socioeconomic Factors
2
2011
579
0.030
 Why?
Learning Curve
1
2015
18
0.030
 Why?
Groin
1
2015
16
0.030
 Why?
Tissue Array Analysis
1
2015
45
0.030
 Why?
Oncology Service, Hospital
1
2014
15
0.030
 Why?
Clinical Trials, Phase III as Topic
1
2015
43
0.030
 Why?
Vinblastine
1
2014
23
0.030
 Why?
Europe
1
2014
76
0.030
 Why?
North America
1
2014
64
0.030
 Why?
Incontinence Pads
1
2014
2
0.030
 Why?
In Situ Hybridization
1
2014
65
0.030
 Why?
Regression Analysis
1
2015
395
0.030
 Why?
Kidney Failure, Chronic
1
2016
200
0.030
 Why?
Personal Satisfaction
1
2014
75
0.030
 Why?
Amino Acid Substitution
1
2014
82
0.030
 Why?
Anxiety
1
2016
275
0.030
 Why?
Gene Dosage
1
2014
78
0.030
 Why?
Gene Expression Regulation, Neoplastic
1
2018
828
0.030
 Why?
Methotrexate
1
2014
69
0.030
 Why?
Ultrasonography
1
2016
437
0.030
 Why?
United States Department of Veterans Affairs
1
2015
288
0.030
 Why?
Survivors
1
2014
125
0.030
 Why?
Papillomaviridae
1
2014
102
0.030
 Why?
Dysuria
1
2013
1
0.030
 Why?
Prevalence
1
2016
951
0.030
 Why?
Sequence Analysis, DNA
1
2014
238
0.030
 Why?
Cluster Analysis
1
2014
235
0.030
 Why?
Anesthesiology
1
2014
45
0.030
 Why?
Intention to Treat Analysis
1
2013
27
0.030
 Why?
Valsalva Maneuver
1
2013
7
0.030
 Why?
Stents
1
2016
343
0.030
 Why?
Diagnostic Tests, Routine
1
2013
29
0.030
 Why?
Paclitaxel
1
2013
84
0.030
 Why?
Health Services Research
1
2013
151
0.030
 Why?
Doxorubicin
1
2014
239
0.030
 Why?
Confidence Intervals
1
2013
156
0.030
 Why?
Antibiotics, Antineoplastic
1
2013
81
0.030
 Why?
Neutropenia
1
2013
115
0.030
 Why?
Thrombocytopenia
1
2013
84
0.030
 Why?
Survival Analysis
1
2014
666
0.030
 Why?
Angiomyolipoma
1
2012
10
0.030
 Why?
Attitude of Health Personnel
1
2015
351
0.030
 Why?
Unnecessary Procedures
1
2012
20
0.030
 Why?
Tertiary Care Centers
1
2012
76
0.030
 Why?
Neoplasm, Residual
1
2013
165
0.020
 Why?
Pilot Projects
1
2014
697
0.020
 Why?
Neoplasms, Multiple Primary
1
2012
44
0.020
 Why?
Biopsy, Fine-Needle
1
2012
103
0.020
 Why?
Patient Positioning
1
2011
32
0.020
 Why?
Urination Disorders
1
2010
23
0.020
 Why?
Disease Management
1
2012
176
0.020
 Why?
Organ Size
1
2010
225
0.020
 Why?
Comorbidity
1
2012
613
0.020
 Why?
Health Status Disparities
1
2011
194
0.020
 Why?
Intraoperative Period
1
2007
45
0.020
 Why?
Erythrocyte Transfusion
1
2006
46
0.020
 Why?
Costs and Cost Analysis
1
2006
91
0.020
 Why?
Decision Trees
1
2005
19
0.020
 Why?
Portal System
1
2005
16
0.020
 Why?
Hypertension, Portal
1
2005
18
0.020
 Why?
Collateral Circulation
1
2005
39
0.020
 Why?
Reoperation
1
2006
454
0.010
 Why?
Short Bowel Syndrome
1
2004
16
0.010
 Why?
Blood Transfusion
1
2005
126
0.010
 Why?
Necrosis
1
2004
178
0.010
 Why?
Liver Transplantation
1
2005
150
0.010
 Why?
Polymorphism, Genetic
1
2002
181
0.010
 Why?
Genetic Markers
1
2002
102
0.010
 Why?
Statistics, Nonparametric
1
2002
193
0.010
 Why?
Base Sequence
1
2002
644
0.010
 Why?
Polymerase Chain Reaction
1
2002
454
0.010
 Why?
Molecular Sequence Data
1
2002
793
0.010
 Why?
Montgomery's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (437) concept(s)
_
Co-Authors Expand Description
See all (1) people
_
Similar People Expand Description
See all (27) people
_
Same Department Expand Description
Search Department